Literature DB >> 3023408

The receptor for urokinase-plasminogen activator.

F Blasi, M P Stoppelli, M V Cubellis.   

Abstract

Many human cells and cell lines possess a specific receptor that binds urokinase plasminogen activator (uPA) with an affinity of about 10(-10) M. Bound enzyme is not internalized, is slowly dissociated, and retains its enzymatic activity. The amino acid sequence of uPA responsible for receptor binding is located within the first 35 aminoterminal residues, ie, in the growth factor domain. Binding, however, is not competed for by other proteins that contain the growth factor domain (including epidermal growth factor). Cells that produce uPA secrete the pro-uPA form, which subsequently binds to the receptor. A431 cells, in fact, have their receptors completely saturated with pro-uPA. It is proposed that uPA:uPA-receptor interaction plays a direct role in physiological and pathological processes that require cell migration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023408     DOI: 10.1002/jcb.240320303

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.

Authors:  Evelyn C Nieves; Naveen Manchanda
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

3.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

4.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 5.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

6.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

7.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

9.  Plasminogen activation in healing human wounds.

Authors:  B M Schäfer; K Maier; U Eickhoff; R F Todd; M D Kramer
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Nuclear translocation of urokinase-type plasminogen activator.

Authors:  Victoria Stepanova; Tatiana Lebedeva; Alice Kuo; Serge Yarovoi; Sergei Tkachuk; Sergei Zaitsev; Khalil Bdeir; Inna Dumler; Michael S Marks; Yelena Parfyonova; Vsevolod A Tkachuk; Abd Al-Roof Higazi; Douglas B Cines
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.